Please login to the form below

Corlaner

This page shows the latest Corlaner news and features for those working in and with pharma, biotech and healthcare.

Amgen takes aim at cardio diseases with Arrowhead RNAi deal

Amgen is a recent entrant into the cardiovascular drugs arena, with recently-approved cholesterol-lowering drug Repatha (evolocumab) and heart failure drug Corlaner (ivabradine) spearheading its assault on the market.

Latest news

Amgen starts shipping Corlaner in US

Amgen starts shipping Corlaner in US. Firm also reports healthy financial growth in the first quarter. ... Amgen has started shipping its Corlaner heart failure therapy to wholesalers in the US just a few days after getting FDA approval for the drug.
FDA clears Amgen's Corlaner for heart failure

FDA clears Amgen's Corlaner for heart failure. It is the firm’ s first cardiovascular product to gain approval. ... Amgen's heart failure drug Corlaner has been given the green light by the US FDA, giving the company its first approved cardiovascular
Amgen banking on three launches in 2015

year. These are evolocumab for high cholesterol, heart failure drug Corlaner (ivabradine) and talimogene laherparepvec (T-VEC) for melanoma. ... Despite the upbeat comments, Amgen did reveal that Corlaner and T-VEC have both been delayed by requests for
Amgen gets priority review for chronic heart failure hope

Raises expectations for early entry onto US market for ivabradine

More from news
Approximately 2 fully matching, plus 3 partially matching documents found.

Latest Intelligence

Heart failure therapy embarks on a new era

Corlaner costs around the same as Entresto at around $4, 500 per year. ... Entresto and Corlaner are expected to account for the bulk of that increase, with Entresto taking the lion's share.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Digital Account Director – Health/ Pharma – Global Agency: Salary TBC

Senior Account Manager – Healthcare Advertising: Salary TBC

Technical Manager – Developer and Commercial Excellence, Healthc...: Excellent package

Market Access Consultant - Greater Manchester: Negotiable

Sudler London - Account Director: Competitive

Senior Account Manager / Account Director - Medical Education – ...: Salary TBC

Systematic Review Lead- London: Negotiable

Account Manager- 4 days per week or full-time: Salary TBC

Account Manager, MedicalCommunications/ Healthcare PR: benefits

Sudler London - Senior Medical Writer: Competitive

Senior Medical Writer, MedComms Agency: Salary TBC

Healthcare PR Senior Account Manager: Salary TBC

Senior Medical Writer, MedComms Agency: £40 - 55, 000 according to skills and experience benefits

Leadership opportunity, Pricing & Market Access, UK, Substan...: Substantial six figure package

Senior/ Market Access Consultant, UK, HOME BASED, £50-60K: Excellent package

Senior Strategist/ Planner, Healthcare Marketing, London: Excellent package

Science Writer, Healthcare Advertising Agency: £40, 000 - 45, 000 DOE benefits,

Senior Medical Writer, Principal Medical Writer, Scientific Dire...: £40000 - £75000 Bonus Benefits

Account Director or Senior Account Director: Salary TBC

Editorial Director – Medical Education: Neg

Senior Writer, Healthcare Advertising, London: Excellent package

Deputy Managing Director – Healthcare PR – Global Agency: Negotiable

Account Director, Medical Communications & Events: £50 - 65, 000 according to skills and experience benefits

Integrated Brand/ Digital Senior Account Director, London: Excellent package

Account Director, Healthcare Communications Agency: £54, 000- £60, 000

Subscribe to our email news alerts

PMHub

Add my company

Merrill Brink International

Merrill Brink International is a leading provider of life sciences, legal, financial, manufacturing and corporate language solutions for global companies....

Latest intelligence

PM Society Digital Awards – the power of together: Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduce anyone in four simple steps: You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government: GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....